Price T Rowe Associates Inc Pacira Bio Sciences, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 50,715 shares of PCRX stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,715
Previous 249,144 79.64%
Holding current value
$1.05 Million
Previous $7.13 Million 89.28%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$11.7 - $28.46 $2.32 Million - $5.65 Million
-198,429 Reduced 79.64%
50,715 $764,000
Q2 2024

Aug 14, 2024
SELL
$25.5 - $31.51 $2.11 Million - $2.61 Million
-82,876 Reduced 24.96%
249,144 $7.13 Million
Q1 2024

May 15, 2024
SELL
$27.7 - $35.48 $1.99 Million - $2.55 Million
-71,733 Reduced 17.77%
332,020 $9.7 Million
Q4 2023

Feb 14, 2024
SELL
$26.32 - $34.31 $137,811 - $179,647
-5,236 Reduced 1.28%
403,753 $13.6 Million
Q3 2023

Nov 14, 2023
BUY
$30.68 - $40.09 $44,393 - $58,010
1,447 Added 0.36%
408,989 $12.5 Million
Q2 2023

Aug 14, 2023
BUY
$36.12 - $47.5 $45,366 - $59,660
1,256 Added 0.31%
407,542 $16.3 Million
Q1 2023

May 15, 2023
BUY
$35.53 - $43.38 $76,886 - $93,874
2,164 Added 0.54%
406,286 $16.6 Million
Q4 2022

Feb 14, 2023
BUY
$38.19 - $57.45 $421,923 - $634,707
11,048 Added 2.81%
404,122 $15.6 Million
Q3 2022

Nov 14, 2022
BUY
$51.24 - $58.89 $224,636 - $258,173
4,384 Added 1.13%
393,074 $20.9 Million
Q2 2022

Aug 15, 2022
BUY
$51.49 - $81.64 $562,528 - $891,917
10,925 Added 2.89%
388,690 $22.7 Million
Q1 2022

May 16, 2022
BUY
$60.03 - $76.49 $138,309 - $176,232
2,304 Added 0.61%
377,765 $28.8 Million
Q4 2021

Feb 14, 2022
BUY
$47.97 - $62.21 $185,787 - $240,939
3,873 Added 1.04%
375,461 $22.6 Million
Q3 2021

Nov 15, 2021
SELL
$54.64 - $61.3 $112,776 - $126,523
-2,064 Reduced 0.55%
371,588 $20.8 Million
Q2 2021

Aug 16, 2021
BUY
$59.18 - $69.99 $573,395 - $678,133
9,689 Added 2.66%
373,652 $22.7 Million
Q1 2021

May 17, 2021
SELL
$59.31 - $78.82 $315,885 - $419,795
-5,326 Reduced 1.44%
363,963 $25.5 Million
Q4 2020

Feb 16, 2021
BUY
$50.47 - $66.26 $18.6 Million - $24.5 Million
369,289 New
369,289 $22.1 Million

Others Institutions Holding PCRX

# of Institutions
263
Shares Held
50.4M
Call Options Held
429K
Put Options Held
391K
View Full List

About Pacira BioSciences, Inc.

PCRX Quotes by TradingView
  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $946M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email